Atul Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 20, 2026

Key Highlights

The Latest Trading Price of Atul Ltd is ₹ 6256 as of 20 Mar 12:41 . The P/E Ratio of Atul Ltd changed from 32 on March 2021 to 37.3 on March 2025 . This represents a CAGR of 3.11% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Atul Ltd changed from ₹ 20935 crore on March 2021 to ₹ 18058 crore on March 2025 . This represents a CAGR of -2.91% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Atul Ltd for the Dec '25 is ₹ 1613 crore as compare to the Sep '25 revenue of ₹ 1601 crore. This represent the growth of 0.75% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Atul Ltd for the Dec '25 is ₹ 286.98 crore as compare to the Sep '25 ebitda of ₹ 317.17 crore. This represent the decline of -9.52% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Atul Ltd changed from ₹ 112.07 crore to ₹ 163.54 crore over 7 quarters. This represents a CAGR of 24.11% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Atul Ltd changed from 9.39 % on March 2021 to 16.14 % on March 2025 . This represents a CAGR of 11.44% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Atul Ltd

Atul Limited, a diversified Indian company, a part of Lalbhai Group, is mainly engaged in the business of Life Science Chemicals and Performance and Other Chemicals meeting the needs of varied industries such as Adhesives, Agriculture, Animal Feed, Automobile, Composites, Construction, Cosmetic, Defence, Dyestuff, Electrical and Electronics, Foam and Furnishing, Flavour, Food, Footwear, Fragrance, Glass, Handicraft, Home Care, Horticulture, Hospitality, Paint and Coatings, Paper, Personal Care, Pharmaceutical, Plastic, Rubber, Soap and Detergent, Sport and Leisure, Textile, Tyre and Wind Energy. Promoted by Kasturbhai Lalbhai, the Company was incorporated on September 5, 1947 and is presently engaged in the business of manufacturing dyes and dye intermediates, agro-chemicals, aromatic like para-Anisaldehyde, epoxy resins and pharma intermediates.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Atul Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Atul Ltd or Saroja Pharma Industries India Ltd?

Market cap of Atul Ltd is 18,324 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Atul Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Atul Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Atul Ltd and Saroja Pharma Industries India Ltd?

As of March 20, 2026, the Atul Ltd stock price is INR ₹6223.95. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹29.6.

How do dividend payouts of Atul Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Atul Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.